Work

OAB-003: Phase 1 study of CART-ddBCMA, a CAR-T therapy utilizing a novel synthetic binding domain for the treatment of subjects with relapsed and refractory multiple myeloma

Year: 2022

Type: conference-abstract

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(22)00276-2

Authors: Matthew Frigault, Jacalyn Rosenblatt, Noopur Raje, Daniella Cook, Mahmoud Gaballa, Estelle Emmanuel-Alejandro, Christine Cornwell, Kamalika Banerjee, Anand Rotte, Christopher Heery, David Avigan, Andrzej Jakubowiak, Michael Bishop

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4293092687

Cites:

Cited by: 1

Related to: 10